In contrast, ANOVA revealed no significant treatment effects on bFGF striatal expression (one-factor ANOVA; F (3, 24) = 0.395, p = 0.7575) indicating that the bFGF level of the infarcted striatum of stroke rats in 24h group did not increase compared to that of control group and the intact striatum of rats in both groups (Fig 7B and S4 Data). Here, FGF2 is linked to stroke disorder.